SBIR/STTR Research Award

STABLE SUPPRESSION OF GENE FUNCTION IN MAMMALS BY RNAI

Award identifier f9342e3a11671068719f4a7b66259c4fec88df69f301295a5a1ec5869a6d7f50Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$707,990

Program and phase

SBIR · Phase II

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
GENETICA, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Cultured mammalian cells are the most commonly used model organisms, both in academic and in industrial biology. However, the tools that are available for manipulating these cells have been relatively primative compared to those available in other model organisms, such as C. elegans and Drosophila. It has been the primary mission of Genetica to develop technologies that improve the ability to manipulate mammalian cells in culture. A collateral benefit of such studies will also be improved technologies to manipulate mammalian model organisms. Genetica has developed a suite of tools, the MaRX system, which enable forward genetics to be harnessed to address numerous biological problems in cell culture. However, to date, we have most often used this system for rescue of phenotypes by ectopic expression. The goal of this proposal is to develop the ability to use double-stranded RNA-induced gene silencing (RNAi) as a tool for stable suppression of gene function in mammalian cells. This goal is strongly rooted in promising preliminary data that predicts the ultimate success of this endeavor. Such success would revolutionize the ability of investigators studying mammalian cells to determine gene function and would thus have profound affects on the identification and validation of potential therapeutic targets. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.